Acasti Pharma Inc (ACST) stock has gained 11.08% while the S&P 500 is down -0.02% as of 1:10 PM on Thursday, Jan 21. ACST has gained $0.08 from the previous closing price of $0.76 on volume of 180,512,526 shares.

Alex Ruus of Arrow Capital gives his outlook for shares of Acasti Pharma.

Acasti Pharma is a biopharmaceutical innovator advancing a potentially best-in-class cardiovascular drug, CaPre® (omega-3 phospholipid), for the treatment of hypertriglyceridemia, a chronic condition affecting an estimated one third of the… Acasti Pharma Announces the Election of Its Directors, Advisory Resolution Approving Compensation, Amendments to Its Stock Option and Equity Incentive Plans, Adoption of Amended & Restated General By-Law and Other Related Matters Approved at Its AGM View Acasti Pharma, Inc. ACST investment & stock information. Get the latest Acasti Pharma, Inc. ACST detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. 2021-04-01 · Oppenheimer have made an estimate for Acasti Pharma Inc. shares, keeping their opinion on the stock as Perform, with their previous recommendation back on September 01, 2020. The new note on the price target was released on July 06, 2020, representing the official price target for Acasti Pharma Inc. stock. Acasti Pharma Inc. (ACST) Add to watchlist. NasdaqCM - NasdaqCM Real Time Price.

Acasti pharma stock

Get the latest Acasti Pharma, Inc. ACST detailed stock quotes, stock data, Real-Time ECN, charts Acasti Pharma, Inc. engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. ValuEngine. A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable Real time Acasti Pharma (Class A) (ACST) stock price quote, stock graph, news & analysis. Looking to buy Acasti Pharma stock?

Today

Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Acasti Pharma against related stocks people have also bought like ONTX, CTRM, NAK, and NAKD. Get the latest Acasti Pharma Inc (ACST) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

On average, Wall Street analysts predict that . Acasti Pharma's share price could stay at $0.92 by Sep 2, 2021. The average Acasti Pharma stock price prediction forecasts a potential downside of N/A from the current ACST share price of $0.54.

2020-01-29 Get the latest Acasti Pharma Inc (ACST) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. 2021-04-05 2021-04-09 2021-03-30 1 day ago 2021-03-25 View the real-time ACST price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Acasti Pharma against related stocks people have … Top Stocks; Stock Picks. Today's 52-Week Highs; Today's 52-Week Lows; Volume Shockers; Price Shockers; High-yield Stocks; The Best Blue-Chip Stocks; AdChoices.

Acasti Pharma stock price target cut to $2 from $8 at B. Riley FBR Jan. 14, 2020 at 8:56 a.m.
Varfor ar jorden rund

Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. Få detaljerad information om Acasti Pharma Inc (ACST) aktie inklusive kurs, diagram, tekniska analyser, empirisk data, Acasti Pharma rapporter och mycket mer.

MAKE SURE TO LIKE AND SUBSCRIBE FOR MORE CONTENTAsk questions in the comments i'm here to help!By Joining this Discord you acknowledge that it is not Financi 2021-04-05 · Acasti Pharma Inc. (NASDAQ:ACST)’s Biggest Investors. Upon looking at major shareholders, it appears that insiders hold 2.7% of Acasti Pharma Inc. shares, and 2.2% of them are in the hands of institutional investors.
Vem betalar bouppteckning

1 dag sedan · Acasti Pharma Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.2200 on 02/10/21, with the lowest value was $0.3200 for the same time period, recorded on 01/04/21.

Currency in USD. At Yahoo Finance, you get free stock quotes, up-to-date news, Wall Street Stock Market & Finance report, prediction for the future: You'll find the Acasti Pharma Inc - Class A share forecasts, stock quote and buy / sell signals below. According to present data Acasti Pharma Inc - Class A's ACST shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). Technical Analysis Summary for Acasti Pharma with Moving Average, Stochastics, MACD, RSI, Average Volume. Stocks: 15 20 minute delay (Cboe BZX is real-time), ET. ACST, $ACST, Acasti Pharma Inc stock technical analysis with charts, breakout and price targets, support and resistance levels, and more trend analysis indicators Acasti Pharma EPS beats by $0.01: Feb 9: Acasti Pharma Announces Results for Third Quarter of Fiscal 2021: Jan 27: Acasti Pharma provides update on recent financing activities: Jan 27: Acasti Pharma Provides Update on Recent Financing Activities: Jan 8: 12 Health Care Stocks Moving In Friday's Intraday Session: Jan 4: 63 Biggest Movers From Acasti Pharma Inc (ACST) stock has gained 11.08% while the S&P 500 is down -0.02% as of 1:10 PM on Thursday, Jan 21.

Elsa laurell vegetarisk barnmat

2021-04-05 · To see how Acasti Pharma Inc. stock has been performing today in comparison to its peers in the industry, here are the numbers: ACST stock’s performance was -2.48% at last check in today’s session, and +83.33% in the past year, while Teva Pharmaceutical Industries Ltd (TEVA) has been trading +1.69% in recent session and positioned +35.54%

Post. 0.38.

2020-01-29 · Acasti Pharma stock fell 64% on the news, and though shares rallied 24% the following day, the negative trend has persisted. Monday’s close was ACST’s lowest close since 2018.

View recent trades and share price information for Acasti Pharma Inc NPV A. View today's stock price, news and analysis for Acasti Pharma Inc. (ACST). Barron's also provides information on historical stock ratings, target prices, company Get the latest Acasti Pharma Inc (ACST) real-time quote, historical performance, charts, and other financial information to help you make more informed trading Acasti Pharma stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. View the latest Acasti Pharma Inc. (ACST) stock price, news, historical charts, analyst ratings and financial information from WSJ. ValuEngine. A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable Find the latest Acasti Pharma, Inc. (ACST) stock quote, history, news and other vital information to help you with your stock trading and investing.

Acasti Pharma currently has 3 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in ACST, but not buy more shares or sell existing shares. 2021-03-30 · Analysts gave the Acasti Pharma Inc. (ACST) stock a consensus recommendation rating of Hold, calculated at a mean rating of 2. If we narrow down to specifics, the data shows that none out of 1 analysts rate the stock as a Sell, with a further none assigning it an Overweight rating.